New Study Recognizes Mercury-Autism Biomarkers

New Study Recognizes Mercury-Autism Biomarkers

According to a recent press release by the Coalition for Mercury-Free Drugs (, “A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders,” published in Neurochemical Research (July 2008), recognizes mercury susceptibility markers in patients diagnosed with an autistic spectrum disorder (ASD).

The study evaluated a number of children diagnosed with an ASD. After examining transsulfuration metabolites, the investigators concluded that the patients diagnosed with an ASD showed signs of increased oxidative stress and a decreased detoxification capacity, particularly for mercury. Because routine, clinically available lab testing was used in the study, the researchers suggest making this procedure a standard part of the diagnostic process.

Download the study for more information:

Leave a Reply

Your email address will not be published. Required fields are marked *